TY - JOUR T1 - The Genetic Links to Anxiety and Depression (GLAD) Study: online recruitment into the largest recontactable study of depression and anxiety JF - medRxiv DO - 10.1101/19002022 SP - 19002022 AU - Molly R. Davies AU - Gursharan Kalsi AU - Anamaria Brailean AU - Anthony J. Cleare AU - Jonathan R.I. Coleman AU - Charles J. Curtis AU - Susannah C.B. Curzons AU - Katrina A.S. Davis AU - Kimberley A. Goldsmith AU - Megan Hammond Bennett AU - Matthew Hotopf AU - Christopher Hüebel AU - Jennifer Leng AU - Bethany D. Mason AU - Monika McAtarsney-Kovacs AU - Dina Monssen AU - Elisavet Palaiologou AU - Carmine Pariante AU - Shivani Parikh AU - Alicia J. Peel AU - Katharine A. Rimes AU - Henry C. Rogers AU - Megan Skelton AU - Anna Spaul AU - Eddy L.A. Suarez AU - Bronte L. Sykes AU - Katie M. White AU - Allan H. Young AU - Evangelos Vassos AU - David Veale AU - Janet Wingrove AU - Thalia C. Eley AU - Gerome Breen Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/07/22/19002022.abstract N2 - Background Anxiety and depression are common, debilitating and costly. These disorders are influenced by multiple risk factors, from genes to psychological vulnerabilities and environmental stressors but research is hampered by a lack of sufficiently large comprehensive studies. We are recruiting 40,000 individuals with lifetime depression or anxiety, with broad assessment of risks to facilitate future research.Methods The Genetic Links to Anxiety and Depression (GLAD) Study (www.gladstudy.org.uk) recruits individuals with depression or anxiety into the NIHR Mental Health BioResource. Participants invited to join the study (via media campaigns) provide demographic, environmental and genetic data, and consent for medical record linkage and recontact.Results Online recruitment was effective; 41,892 consented and 26,877 participants completed the questionnaire by July 2019. Participants’ questionnaire data identified very high rates recurrent depression, severe anxiety and comorbidity. Participants reported high rates of treatment receipt. The age profile of sample is biased toward young adults, with higher recruitment of females and the better educated, especially at younger ages.Discussion This paper describes the study methodology and descriptive data for GLAD, which represents a large, recontactable resource that will enable future research into risks, outcomes and treatment for anxiety and depression.HighlightsOnline recruitment of 40,000 individuals with lifetime depression or anxiety (77 characters)Detailed online phenotyping combined with genetic and clinical data (66 characters)The study sample is severe, highly comorbid, with chronic psychopathology (62 characters)The study protocol enables recall of participants for future research and trials (82 characters)HighlightsThe views expressed are those of the authors and not necessarily those of the NHS, NIHR, Department of Health or King’s College LondonCompeting Interest StatementThe authors have declared no competing interest.Funding StatementUK NIHRAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesThis is a cohort description paper.SNPsingle nucleotide polymorphismGLADGenetic Links to Anxiety and DepressionNIHRNational Institute for Health ResearchIAPTImproving Access to Psychological TherapiesSLaMSouth London and MaudsleyNHSNational Health ServiceSUREService User Research EnterpriseFAST-RFeasibility and Acceptability Support Team for ResearchersPRpublic relationsSOPsstandard operating proceduresCRNClinical Research NetworksGPgeneral practitionerCCGClinical Commissioning Group ER -